Shanghai Runda Medical Technology Dividends and Buybacks
Dividend criteria checks 2/6
Shanghai Runda Medical Technology is a dividend paying company with a current yield of 0.58%.
Key information
0.6%
Dividend yield
-0.2%
Buyback Yield
Total Shareholder Yield | 0.4% |
Future Dividend Yield | 0% |
Dividend Growth | 9.7% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.100 |
Payout ratio | 154% |
Recent dividend and buyback updates
No updates
Recent updates
Earnings Tell The Story For Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) As Its Stock Soars 39%
Oct 22These 4 Measures Indicate That Shanghai Runda Medical Technology (SHSE:603108) Is Using Debt Extensively
Oct 18Shanghai Runda Medical Technology (SHSE:603108) Has A Somewhat Strained Balance Sheet
Jun 26Shanghai Runda Medical Technology Co., Ltd.'s (SHSE:603108) Earnings Haven't Escaped The Attention Of Investors
Jun 04Does Shanghai Runda Medical Technology (SHSE:603108) Deserve A Spot On Your Watchlist?
Mar 21Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) Stock Rockets 31% But Many Are Still Ignoring The Company
Mar 04These 4 Measures Indicate That Shanghai Runda Medical Technology (SHSE:603108) Is Using Debt Extensively
Feb 27Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 603108 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 603108's dividend payments have increased, but the company has only paid a dividend for 9 years.
Dividend Yield vs Market
Shanghai Runda Medical Technology Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (603108) | 0.6% |
Market Bottom 25% (CN) | 0.5% |
Market Top 25% (CN) | 2.1% |
Industry Average (Life Sciences) | 1.2% |
Analyst forecast (603108) (up to 3 years) | 0% |
Notable Dividend: 603108's dividend (0.58%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 603108's dividend (0.58%) is low compared to the top 25% of dividend payers in the CN market (2.15%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (154.1%), 603108's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (13.1%), 603108's dividend payments are thoroughly covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 07:03 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai Runda Medical Technology Co., Ltd. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jin Zhang | China International Capital Corporation Limited |
Xiao Wei Lin | Everbright Securities Co. Ltd. |
Lin Yang | Haitong International Research Limited |